R&D Trends

Drug sponsors join research partnership to accelerate drug discovery

Thursday, September 29, 2011 01:21 PM

In a bid to save both time and money, some of the industry's biggest names are experimenting with new ways to pool early-stage research, effectively taking a leaf out of the "open-source" manual that gave the world Linux software, according to Reuters.

More... »

EGEN, Nanotechnology Characterization Lab collaborate in brain cancer research

Tuesday, September 27, 2011 11:09 AM

EGEN is collaborating with the National Cancer Institute'sNanotechnology Characterization Laboratory in Frederick, Md., to accelerate human clinical testing of a nanotechnology-based gene therapy for brain cancer.

More... »

AstraZenca seeks partners in China

Friday, September 23, 2011 02:28 PM

AstraZeneca will continue its cooperation model on research and development (R&D) in China instead of merger and acquisition (M&A), the company's executive said, according to China Daily.

More... »

Merck opens R&D facility in Ireland

Thursday, September 22, 2011 11:27 AM

More good news for the Irish pharmaceutical industry has come with the official opening of Merck's new 100 million euro R&D facility at Ballydine, Co Tipperary, according to PharmaTimes.

More... »

Nuevolution, Boehringer collaborate in drug discovery

Tuesday, September 20, 2011 12:22 PM

Nuevolution has entered into a collaboration with Boehringer Ingelheim, using Nuevolution’s proprietary Chemetics drug discovery technology.

More... »

Hematech cuts 18 jobs in Sioux Falls facility

Tuesday, September 20, 2011 10:50 AM

Hematech, a Sioux Falls' flagship biotechnology research company, has laid off 18 people in response to the changing needs of its parent company, according to ArgusLeader.

More... »

Selcia, NeuroVice partner to generate mitochondrial compounds

Tuesday, September 20, 2011 10:08 AM

Selcia, the UK-based contract research organization that recently extended its international reach with a facility in the US, has agreed to collaborate with Swedish drug development company NeuroVive Pharmaceutical on generating new compounds targeted at mitochondrial physiology and pathophysiology, according to PharmaTimes.

More... »

General Electric leads $100 million fund for breast cancer challenge

Thursday, September 15, 2011 02:03 PM

General Electric joined four venture capital firms in pledging $100 million for a six-month contest to finance ideas for improving breast cancer detection, according to Bloomberg.

More... »

PharmaNet, McGill to develop Canadian translational research facility

Thursday, September 15, 2011 10:52 AM

PharmaNet Development Group, the US-based clinical development services provider acquired by inVentiv Health, has teamed up with a Canadian research institute to set up what the company says will be the country’s first in-hospital translational medicine unit for phase I-IIa clinical trials, according to PharmaTimes.

More... »

Pharmaron to host Merck’s R&D laboratory in China

Wednesday, September 14, 2011 02:13 PM

Pharmaron has reported a strategic partnership with Merck Serono. In the framework of this partnership, Pharmaron's new campus in the Beijing economic and technological development area (BDA) will serve as home to Merck Serono's China R&D laboratory.

More... »